F. Zahran, A. Nabil, Amr El Karef, A. Lotfy, K. Mahmoud, W. Hozayen, M. Sobh
{"title":"Effect of antioxidants and mesenchymal stem cells on cisplatin induced renal fibrosis in rats","authors":"F. Zahran, A. Nabil, Amr El Karef, A. Lotfy, K. Mahmoud, W. Hozayen, M. Sobh","doi":"10.15406/JSRT.2016.01.00026","DOIUrl":null,"url":null,"abstract":"1.1.Background:Mesenchymal stem cells (MSCs) have generated a great deal of excitement and promise as a potential source of all types of cells for cell-based therapeutic strategies. The reparative role of MSCs may be multifunctional and include the secretion of anti-inflammatory cytokines like TGFβ1 to limit apoptosis and dampen the inflammatory response. There are reports suggesting that antioxidants such as N N'-diphenyl-1, 4-phenylenediamine (DPPD) inhibit interstitial fibrosis induced by cisplatin. It inhibits lipid peroxidation and nephrotoxicity induced by cisplatin, where antioxidants make trapping for free radicals. \n \n 1.2.Aim:We aimed to investigate the inhibitory potential of either stem cells or DPPD on renal fibrosis in cisplatin induced tubulointerstitial fibrosis rat model. \n \n 1.3.Materials and methods:This study was carried on 40 male Sprague-Dawley rats (body weight 170 - 220 g). Rats were divided into 4 groups as follow: Control group, received intravenous saline. Cisplatin group, received cisplatin (6 mg/kg, i.p). DPPD group, received cisplatin (6 mg/kg, i.p) at the start of experiments and three days after cisplatin administration, rats were given DPPD (0.5 g/kg, i.p) every two days. MSCs group, received cisplatin (6 mg/kg, i.p) at the start of experiments and three days after cisplatin administration, rats were given MSCs (1 ×106, i.v) single dose. 14 days after cisplatin (or saline) administration, blood samples were obtained and kidneys were removed for biochemical, histopathology and immunohistochemical markers investigations. \n \n 1.4.Results:In addition to the significant rise in urea and creatinine, cisplatin group showed atrophied glomeruli with tubular cells vacuolization and increased collagen deposition. Alpha smooth muscle actin (α-SMA) and fibroblast proliferation marker Ki-67 were found to be increased in renal tissue. Lipid peroxidation and collagen formation markers showed significant elevation. Both MSCs and antioxidant ameliorated cisplatin-induced nephrotoxicity to a great extent and showed marvelous anti-fibrotic effect as evidenced by histopathological, immunohistochemical and biochemical assessments. \n \n 1.5.Conclusion:Both MSCs and antioxidant (DPPD) were found to have potent potentials to inhibit tubulointerstitial fibrosis in cisplatin induced nephrotoxicity rat model.","PeriodicalId":91560,"journal":{"name":"Journal of stem cell research & therapeutics","volume":"13 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2016-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of stem cell research & therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/JSRT.2016.01.00026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7
Abstract
1.1.Background:Mesenchymal stem cells (MSCs) have generated a great deal of excitement and promise as a potential source of all types of cells for cell-based therapeutic strategies. The reparative role of MSCs may be multifunctional and include the secretion of anti-inflammatory cytokines like TGFβ1 to limit apoptosis and dampen the inflammatory response. There are reports suggesting that antioxidants such as N N'-diphenyl-1, 4-phenylenediamine (DPPD) inhibit interstitial fibrosis induced by cisplatin. It inhibits lipid peroxidation and nephrotoxicity induced by cisplatin, where antioxidants make trapping for free radicals.
1.2.Aim:We aimed to investigate the inhibitory potential of either stem cells or DPPD on renal fibrosis in cisplatin induced tubulointerstitial fibrosis rat model.
1.3.Materials and methods:This study was carried on 40 male Sprague-Dawley rats (body weight 170 - 220 g). Rats were divided into 4 groups as follow: Control group, received intravenous saline. Cisplatin group, received cisplatin (6 mg/kg, i.p). DPPD group, received cisplatin (6 mg/kg, i.p) at the start of experiments and three days after cisplatin administration, rats were given DPPD (0.5 g/kg, i.p) every two days. MSCs group, received cisplatin (6 mg/kg, i.p) at the start of experiments and three days after cisplatin administration, rats were given MSCs (1 ×106, i.v) single dose. 14 days after cisplatin (or saline) administration, blood samples were obtained and kidneys were removed for biochemical, histopathology and immunohistochemical markers investigations.
1.4.Results:In addition to the significant rise in urea and creatinine, cisplatin group showed atrophied glomeruli with tubular cells vacuolization and increased collagen deposition. Alpha smooth muscle actin (α-SMA) and fibroblast proliferation marker Ki-67 were found to be increased in renal tissue. Lipid peroxidation and collagen formation markers showed significant elevation. Both MSCs and antioxidant ameliorated cisplatin-induced nephrotoxicity to a great extent and showed marvelous anti-fibrotic effect as evidenced by histopathological, immunohistochemical and biochemical assessments.
1.5.Conclusion:Both MSCs and antioxidant (DPPD) were found to have potent potentials to inhibit tubulointerstitial fibrosis in cisplatin induced nephrotoxicity rat model.